On Tuesday, Vanda Pharmaceuticals Inc (NASDAQ: VNDA) was 21.59% up from the session before settling in for the closing price of $4.4. A 52-week range for VNDA has been $3.81 – $5.70.
When this article was written, the company’s average yearly earnings per share was at -595.45%. With a float of $55.08 million, this company’s outstanding shares have now reached $59.10 million.
Vanda Pharmaceuticals Inc (VNDA) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Vanda Pharmaceuticals Inc stocks. The insider ownership of Vanda Pharmaceuticals Inc is 6.79%, while institutional ownership is 77.00%. The most recent insider transaction that took place on Aug 07 ’25, was worth 41,500. In this transaction President and CEO of this company bought 10,000 shares at a rate of $4.15, taking the stock ownership to the 2,335,731 shares. Before that another transaction happened on Jun 13 ’25, when Company’s Director sold 7,000 for $4.59, making the entire transaction worth $32,130. This insider now owns 97,082 shares in total.
Vanda Pharmaceuticals Inc (VNDA) Recent Fiscal highlights
Going through the last 3-months fiscal report unveiled on the 12/31/2024, it has been observed that the corporation posted -0.08 earnings per share (EPS) during the time that was better than consensus figure (set at -0.11) by 0.03. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.43 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -595.45% per share during the next fiscal year.
Vanda Pharmaceuticals Inc (NASDAQ: VNDA) Trading Performance Indicators
You can see what Vanda Pharmaceuticals Inc (VNDA) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 3.10. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.49.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.43, a number that is poised to hit -0.96 in the next quarter and is forecasted to reach -1.48 in one year’s time.
Technical Analysis of Vanda Pharmaceuticals Inc (VNDA)
Analysing the last 5-days average volume posted by the [Vanda Pharmaceuticals Inc, VNDA], we can find that recorded value of 1.36 million was better than the volume posted last year of 0.58 million. As of the previous 9 days, the stock’s Stochastic %D was 60.04%.
During the past 100 days, Vanda Pharmaceuticals Inc’s (VNDA) raw stochastic average was set at 77.56%, which indicates a significant decrease from 90.76% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.23 in the past 14 days, which was higher than the 0.19 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $4.90, while its 200-day Moving Average is $4.63. Now, the first resistance to watch is $5.66. This is followed by the second major resistance level at $5.96. The third major resistance level sits at $6.47. If the price goes on to break the first support level at $4.85, it is likely to go to the next support level at $4.34. Now, if the price goes above the second support level, the third support stands at $4.04.
Vanda Pharmaceuticals Inc (NASDAQ: VNDA) Key Stats
There are 59,097K outstanding shares of the company, which has a market capitalization of 316.17 million. As of now, sales total 198,770 K while income totals -18,900 K. Its latest quarter income was 56,260 K while its last quarter net income were -22,590 K.
